Is Dhanvantri Jeev. overvalued or undervalued?

Sep 27 2025 08:01 AM IST
share
Share Via
As of September 26, 2025, Dhanvantri Jeev. is fairly valued with a PE ratio of 12.20, an EV to EBITDA of 9.65, and a PEG ratio of 0.26, showing lower valuations compared to peers like Max Healthcare and Apollo Hospitals, while outperforming the Sensex with a year-to-date return of 33.04%.
As of 26 September 2025, the valuation grade for Dhanvantri Jeev. has moved from very attractive to attractive. The company is currently fairly valued. Key ratios include a PE ratio of 12.20, an EV to EBITDA of 9.65, and a PEG ratio of 0.26, which indicates a relatively low valuation compared to its growth prospects.

In comparison to peers, Dhanvantri Jeev. shows a significantly lower PE ratio than Max Healthcare, which is very expensive at 91.13, and Apollo Hospitals, which is attractive at 68.57. The company's recent stock performance has outpaced the Sensex, with a year-to-date return of 33.04% compared to the Sensex's 2.93%, reinforcing the notion that it is fairly valued within its industry context.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News